Literature DB >> 11673195

Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease.

R A Rabinovich1, E Ardite, T Troosters, N Carbó, J Alonso, J M Gonzalez de Suso, J Vilaró, J A Barberà, M F Polo, J M Argilés, J C Fernandez-Checa, J Roca.   

Abstract

The present study was undertaken to test whether endurance training in patients with COPD, along with enhancement of muscle bioenergetics, decreases muscle redox capacity as a result of recurrent episodes of cell hypoxia induced by high intensity exercise sessions. Seventeen patients with COPD (FEV(1), 38 +/- 4% pred; PaO2), 69 +/- 2.7 mm Hg; PaCO2, 42 +/- 1.7 mm Hg) and five age-matched control subjects (C) were studied pretraining and post-training. Reduced (GSH) and oxidized (GSSG) glutathione, lipid peroxidation, and gamma-glutamyl cysteine synthase heavy subunit chain mRNA expression (gammaGCS-HS mRNA) were measured in the vastus lateralis. Pretraining redox status at rest and after moderate (40% Wpeak) constant-work rate exercise were similar between groups. After training (DeltaWpeak, 27 +/- 7% and 37 +/- 18%, COPD and C, respectively) (p < 0.05 each), GSSG levels increased only in patients with COPD (from 0.7 +/- 0.08 to 1.0 +/- 0.15 nmol/ mg protein, p < 0.05) with maintenance of GSH levels, whereas GSH markedly increased in C (from 4.6 +/- 1.03 to 8.7 +/- 0.41 nmol/ mg protein, p < 0.01). Post-training gammaGCS-HS mRNA levels increased after submaximal exercise in patients with COPD. No evidence of lipid peroxidation was observed. We conclude that although endurance training increased muscle redox potential in healthy subjects, patients with COPD showed a reduced ability to adapt to endurance training reflected in lower capacity to synthesize GSH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673195     DOI: 10.1164/ajrccm.164.7.2103065

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

Authors:  J Garcia-Aymerich; P Lange; M Benet; P Schnohr; J M Antó
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

2.  Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial.

Authors:  Nobuhiro Matsumoto; Keisuke Miki; Hironobu Tsubouchi; Akihiro Sakamoto; Yasuji Arimura; Shigehisa Yanagi; Hirotoshi Iiboshi; Makoto Yoshida; Ryosuke Souma; Hiroshi Ishimoto; Yoshifumi Yamamoto; Kazuhiro Yatera; Masanori Yoshikawa; Hironori Sagara; Tomoaki Iwanaga; Hiroshi Mukae; Ryoji Maekura; Hiroshi Kimura; Masamitsu Nakazato; Kenji Kangawa
Journal:  Lung       Date:  2015-01-30       Impact factor: 2.584

3.  Molecular mechanisms underlying COPD-muscle dysfunction unveiled through a systems medicine approach.

Authors:  Igor Marín de Mas; Eric Fanchon; Balázs Papp; Susana Kalko; Josep Roca; Marta Cascante
Journal:  Bioinformatics       Date:  2016-10-06       Impact factor: 6.937

Review 4.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

5.  Raised CRP levels mark metabolic and functional impairment in advanced COPD.

Authors:  R Broekhuizen; E F M Wouters; E C Creutzberg; A M W J Schols
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

6.  Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.

Authors:  Ioannis Vogiatzis; Grigoris Stratakos; Davina C M Simoes; Gerasimos Terzis; Olga Georgiadou; Charis Roussos; Spyros Zakynthinos
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

7.  Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.

Authors:  Esther Ardite; Joan Albert Barbera; Josep Roca; Jose C Fernández-Checa
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure.

Authors:  Kechun Tang; Peter D Wagner; Ellen C Breen
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

Review 9.  Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders.

Authors:  Kelsey Fisher-Wellman; Heather K Bell; Richard J Bloomer
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

10.  Oxidative and nitrosative stress in the diaphragm of patients with COPD.

Authors:  Hanneke J H Wijnhoven; Leo M A Heunks; Maartje C P Geraedts; Theo Hafmans; José R Viña; P N Richard Dekhuijzen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.